Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 10/20 | 0.38 |
| ▸ | FAAH | O00519 | 6/20 | 0.35 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL354728 | 0.93 | NAAA (0.42) | NAAAFAAH | |
| SCHEMBL3145817 | 0.74 | — | — | |
| SCHEMBL4806247 | 0.70 | NAAA (0.44) | NAAAFAAH | |
| SCHEMBL4806256 | 0.70 | NAAA (0.44) | NAAAFAAH | |
| SCHEMBL7569177 | 0.69 | NAAA (0.48) | NAAAFAAH | |
| Acrylamide SCHEMBL8498177 | 0.69 | ALDH1A1 (0.58) | ALDH1A1TSHRFGFR4BTK | |
| Acrylamide SCHEMBL3714624 | 0.69 | ALDH1A1 (0.58) | ALDH1A1TSHRFGFR4BTK | |
| SCHEMBL18402201 | 0.69 | NAAA (0.39) | NAAAFAAH | |
| SCHEMBL8194221 | 0.69 | NAAA (0.50) | NAAAFAAH | |
| SCHEMBL21641600 | 0.69 | POLB (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262299-B2 | Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse | JOHNSON MATTHEY PLC (GB) | 2007-08-28 | — | — | US | disclosed |
| US-20050033100-A1 | Catalysts | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050033100-A1 | Catalysts | DERA, AGL, INF2 | ALDH1A1 1077/4885TSHR 2840/4885FGFR4 3494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.